Biography
Dr Christos Mikropoulos is a Consultant Clinical Oncologist with extensive experience in the treatment of a wide range of solid tumours, including colorectal cancers.
He completed his medical degree at Aristotle University of Thessaloniki Medical School and subsequently undertook postgraduate training in the UK.
He obtained Membership of the Royal College of Physicians (MRCP) and Fellowship of the Royal College of Radiologists (FRCR).
He holds a Master’s degree in Oncology from Newcastle University and completed an MD (Research) at the Institute of Cancer Research, University of London.
Dr Mikropoulos is actively engaged in advancing the field of prostate cancer through academic research alongside his clinical practice. He is a Principal Investigator to several important studies, including SABRE (Spacing Gel with Prostate SABR), ARASTEP (Addition of Darolutamide to ADT for high risk biochemical relapsed prostate cancer), WAYFIND-R (NGS for solid tumours and correlation with outcomes) at the Royal Surrey Hospital Cancer Centre.
GMC: 4692210
Publications
Biomarkers in Stereotactic Ablative Radiotherapy: Current Evidence and Future Directions, International Journal of Molecular Sciences, 2025, https://www.mdpi.com/3569800
Net survival of men with localized prostate cancer after LDR brachytherapy, Brachytherapy, 2024, Net survival of men with localized prostate cancer after LDR brachytherapy - Brachytherapy
The Application of Radiomics and AI to Molecular Imaging for Prostate Cancer, Journal of Personalized Medicine, 2024, The Application of Radiomics and AI to Molecular Imaging for Prostate Cancer
Prognostic Factors in Patients with Metastatic Spinal Cord Compression Secondary to Lung Cancer—A Retrospective UK Single-Centre Study, Cancers, 2023, Prognostic Factors in Patients with Metastatic Spinal Cord Compression Secondary to Lung Cancer—A Retrospective UK Single-Centre Study
Current Methods and Advances in the Immunotherapy Treatment of Non-Ovarian Gynaecological Cancers, Future Pharmacology, 2023, Current Methods and Advances in the Immunotherapy Treatment of Non-Ovarian Gynaecological Cancers